Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy

Figure 2

The transcriptional level of EPHA/EFNA in breast cancer patients with different subtypes. HER2-positive and triple-negative breast cancer patients tended to express lower levels of EPHA3, EPHA5, EPHA6, and EPHA10 mRNA. The highest mRNA expression of EPHA3, EPHA5, EPHA6, and EPHA10 was found in the luminal subtype. The highest mRNA expression of EFNA was detected in triple-negative tissues except EFNA3, and the lowest mRNA expression of EFNA was detected in the luminal subtype, except for EFNA1.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)